HKSTP and HKTDC Lead Delegation of 60 Tech Companies to CES 2026

Hong Kong, SAR–(Newsfile Corp. – December 12, 2025) – Consumer Electronics Show (CES) 2026, one of the world’s largest technology and innovation event, will take place from 6 to 9 January 2026 in Las Vegas. Hong Kong Science and Technology Parks Corporation (HKSTP), together with the Hong Kong Trade Development Council (HKTDC), supported by the […]

Thunder Gold Announces $2 Million Non-Brokered Private Placement of Flow-Through Units

Thunder Bay, Ontario–(Newsfile Corp. – December 12, 2025) – Thunder Gold Corp. (TSXV: TGOL) (FSE: Z25) (OTCQB: TGOLF) (“Thunder Gold” or the “Company”) is pleased to announce a non-brokered private placement of flow-through units for gross proceeds of up to approximately C$2,000,000 (the “Private Placement”). Proceeds of the Private Placement shall be used to fund

Bobo Digital Launches Smarter AI-Driven Framework for Search Engine Ads

Adelaide, Australia–(Newsfile Corp. – December 12, 2025) – Bobo Digital, a leading Adelaide digital marketing agency, has launched a data-driven approach to search engine ads, helping businesses adapt to AI-powered advertising. Bobo Digital logo To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10587/277260_4082c5703498f90d_001full.jpg The framework uses search engine campaign updates, including audience insights, retention

Streamex Corp. (NASDAQ: STEX) to Provide Corporate Update Webinar Highlighting 2025 Milestones and 2026 Strategic Roadmap on December 16th at 11:00am EST

(NASDAQ:STEX), LOS ANGELES, Dec. 12, 2025 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced that it will host a corporate update webinar on December 16, 2025 at 11:00 AM EST. The event will provide shareholders with a comprehensive review of the

Serve Robotics Builds 2,000 Autonomous Delivery Robots, Creating Largest Sidewalk Delivery Fleet in the U.S.

(NASDAQ:SERV), SAN FRANCISCO, Dec. 12, 2025 (GLOBE NEWSWIRE) — Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today announced that it has officially achieved its 2025 goal of deploying more than 2,000 delivery robots, creating the largest sidewalk delivery fleet in the U.S. as demand for safe, sustainable, and cost-efficient last-mile delivery

Applied Materials Announces Cash Dividend

(NASDAQ:AMAT), SANTA CLARA, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that its Board of Directors has approved a quarterly cash dividend of $0.46 per share payable on the company's common stock. The dividend is payable on March 12, 2026 to shareholders of record as of Feb. 19, 2026. The cash

Glen Burnie Bancorp Announces Intended Voluntary Delisting from Nasdaq and Termination of SEC Registration

(NASDAQ:GLBZ), GLEN BURNIE, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) — Glen Burnie Bancorp (“Bancorp”) (NASDAQ: GLBZ), the bank holding Bancorp for The Bank of Glen Burnie (“Bank”), today announced that Bancorp's board of directors (the “Board”) has approved the voluntarily delisting of Bancorp's common stock (and related common stock purchase rights) from The Nasdaq Capital

Pasinex Receives MAPEG Approval for Horzum AS; Announces 1,000-Metre Development Plan for Pinargozu Mine

(CNSX:PSE.CN),(Boerse Frankfurt – Freiverkehr:PNX),(CNSX:PSE), TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE; FSE: PNX) (“Pasinex” or the “Company”) is pleased to announce that Turkiye's General Directorate of Mining and Petroleum Affairs (“MAPEG”) has approved the transfer of shares in Horzum Arama ve Madencilik AS (“Horzum AS”) from Kurmel Madencilik to Pasinex

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline

Financing funds the global Phase 2b clinical trial in atopic dermatitis and Phase 2 clinical program in molluscum contagiosum AlphynBiologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, today announced the close of its $25 million, twice-oversubscribed Series B financing. Proceeds will fund the Phase 2b global clinical trial of Alphyn's lead drug candidate,

Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18 for Duchenne Muscular Dystrophy

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18 at Peking Union Medical College Hospital (PUMCH) in Beijing. This important milestone represents a significant step forward in developing new therapies for Duchenne Muscular Dystrophy (DMD), providing a

Scroll to Top